178 related articles for article (PubMed ID: 1387095)
1. Fibrinogen/fibrin in atherogenesis.
Smith EB; Thompson WD; Crosbie L; Stirk CM
Eur J Epidemiol; 1992 May; 8 Suppl 1():83-7. PubMed ID: 1387095
[TBL] [Abstract][Full Text] [Related]
2. Does lipoprotein(a) (Lp(a)) complete with plasminogen in human atherosclerotic lesions and thrombi?
Smith EB; Crosbie L
Atherosclerosis; 1991 Aug; 89(2-3):127-36. PubMed ID: 1838924
[TBL] [Abstract][Full Text] [Related]
3. Fibrinogen, fibrin and the arterial wall.
Smith EB
Eur Heart J; 1995 Mar; 16 Suppl A():11-4; discussion 14-5. PubMed ID: 7796823
[TBL] [Abstract][Full Text] [Related]
4. The release of an immobilized lipoprotein fraction from atherosclerotic lesions by incubation with plasmin.
Smith EB; Massie IB; Alexander KM
Atherosclerosis; 1976 Oct; 25(1):71-84. PubMed ID: 186079
[TBL] [Abstract][Full Text] [Related]
5. Factors influencing the accumulation in fibrous plaques of lipid derived from low density lipoprotein. II. Preferential immobilization of lipoprotein (a) (Lp(a)).
Smith EB; Cochran S
Atherosclerosis; 1990 Oct; 84(2-3):173-81. PubMed ID: 2149268
[TBL] [Abstract][Full Text] [Related]
6. Plasmin catalyzes binding of lipoprotein (a) to immobilized fibrinogen and fibrin.
Harpel PC; Gordon BR; Parker TS
Proc Natl Acad Sci U S A; 1989 May; 86(10):3847-51. PubMed ID: 2524834
[TBL] [Abstract][Full Text] [Related]
7. Role of endothelium in sequestration of lipoprotein and firbrinogen in aortic lesions, thrombi, and graft pseudo-intimas.
Smith EB; Staples EM; Dietz HS; Smith RH
Lancet; 1979 Oct; 2(8147):812-6. PubMed ID: 90916
[TBL] [Abstract][Full Text] [Related]
8. [Apo B, fibrinogen-fibrin and fibronectin in the intima of the normal human aorta and large arteries and in atherosclerosis].
Shekhonin BV; Tararak EM; Samokhin GP; Vinogradov DV; Kotelianskiĭ VE
Arkh Patol; 1990; 52(4):16-21. PubMed ID: 2201275
[TBL] [Abstract][Full Text] [Related]
9. Smooth muscle cell outgrowth stimulated by fibrin degradation products. The potential role of fibrin fragment E in restenosis and atherogenesis.
Naito M; Stirk CM; Smith EB; Thompson WD
Thromb Res; 2000 Apr; 98(2):165-74. PubMed ID: 10713318
[TBL] [Abstract][Full Text] [Related]
10. Molecular interactions in human atherosclerotic plaques.
Smith EB
Am J Pathol; 1977 Mar; 86(3):665-74. PubMed ID: 65917
[TBL] [Abstract][Full Text] [Related]
11. The inter-relation of fibrin, lipoprotein(a) and plasminogen in human atherosclerotic lesions.
Smith EB; Crosbie L; Cochran S
Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):495-8. PubMed ID: 2151935
[TBL] [Abstract][Full Text] [Related]
12. Prothrombin-related antigens in human aortic intima.
Smith EB; Crosbie L; Carey S
Semin Thromb Hemost; 1996; 22(4):347-50. PubMed ID: 8944420
[TBL] [Abstract][Full Text] [Related]
13. Factors influencing the accumulation in fibrous plaques of lipid derived from low density lipoprotein. I. Relation between fibrin and immobilization of apo B-containing lipoprotein.
Smith EB; Keen GA; Grant A
Atherosclerosis; 1990 Oct; 84(2-3):165-71. PubMed ID: 2149267
[TBL] [Abstract][Full Text] [Related]
14. Haemostatic factors in human aortic intima.
Smith EB; Staples EM
Lancet; 1981 May; 1(8231):1171-4. PubMed ID: 6112525
[TBL] [Abstract][Full Text] [Related]
15. Fibrinogen, fibrin and fibrin degradation products in relation to atherosclerosis.
Smith EB
Clin Haematol; 1986 May; 15(2):355-70. PubMed ID: 3524931
[TBL] [Abstract][Full Text] [Related]
16. Fate of fibrinogen in human arterial intima.
Smith EB; Keen GA; Grant A; Stirk C
Arteriosclerosis; 1990; 10(2):263-75. PubMed ID: 2317160
[TBL] [Abstract][Full Text] [Related]
17. Factor XIIIa cross-links lipoprotein(a) with fibrinogen and is present in human atherosclerotic lesions.
Romanic AM; Arleth AJ; Willette RN; Ohlstein EH
Circ Res; 1998 Aug; 83(3):264-9. PubMed ID: 9710118
[TBL] [Abstract][Full Text] [Related]
18. Effects of fibrin and fibrinogen-degradation products on the growth of rabbit aortic smooth muscle cells in culture.
Ishida T; Tanaka K
Atherosclerosis; 1982 Aug; 44(2):161-74. PubMed ID: 7138618
[TBL] [Abstract][Full Text] [Related]
19. Fibrin deposition and fibrin degradation products in atherosclerotic plaques.
Smith EB
Thromb Res; 1994 Aug; 75(3):329-35. PubMed ID: 7992244
[TBL] [Abstract][Full Text] [Related]
20. Immunochemical characterization of fibrinogen, fibrin I, and fibrin II in human thrombi and atherosclerotic lesions.
Bini A; Fenoglio J; Sobel J; Owen J; Fejgl M; Kaplan KL
Blood; 1987 Apr; 69(4):1038-45. PubMed ID: 2950941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
